Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement Therapy for BPH with Metabolic Syndrome (PROTEST)
NCT02366975Phase 4Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Nov 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AndroForte in Hypogonadism, benign prostatic hyperplasia (BPH), sponsored by Università degli Studi di Firenze. Started Nov 2012; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypogonadismbenign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02366975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366975.